NCT01234168

A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

An International, Cross Sectional, Non-interventional, Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 340 (actual)
• Sponsor: Ipsen · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the protocol is to to assess subject's overall satisfaction regarding control of diarrhea. The study aims to supplement results obtained through clinical trials with data obtained from a population of patients receiving treatment with Somatuline Autogel in routine practice.

Conditions

• Neuroendocrine Tumors
• Carcinoid Syndrome

Timeline

• Start date: 2010-10-01
• Primary completion: 2012-12-01
• Completion: 2012-12-01
• First posted: 2010-11-04
• Last updated: 2020-11-05

Locations

57 sites across 8 countries: Czechia, France, Hungary, Israel, Italy, Poland, Spain, United Kingdom